NC

January 25, 2017

OBI-822 was approved to enter a Phase III clinical trial by the China Food and Drug Administration (CFDA)

[…]
January 23, 2017

OBI Pharma Inc. announces the change of Chief Operating Officer

[…]
January 21, 2017

Clarification on the news article by Commercial Times

[…]
January 11, 2017

Clarification on the news article by United Daily News E-Paper

[…]